Jae-Ryong Kim Selected Research

Jae-Ryong Kim Research Topics

Disease

26	Neoplasms (Cancer) 06/2022 - 01/2003
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2006
12	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2003
11	Inflammation (Inflammations) 01/2021 - 02/2007
9	Atherosclerosis 01/2021 - 12/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2015
5	Hepatocellular Carcinoma (Hepatoma) 05/2010 - 11/2002
4	Body Weight (Weight, Body) 03/2024 - 04/2007
4	Hypertension (High Blood Pressure) 01/2021 - 02/2018
3	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 02/2004
3	Fibrosis (Cirrhosis) 01/2022 - 01/2018
3	Dementia (Dementias) 01/2021 - 10/2019
3	Hyperlipidemias (Hyperlipidemia) 03/2018 - 06/2010
3	Alzheimer Disease (Alzheimer's Disease) 05/2008 - 10/2003
2	Infections 02/2021 - 12/2010
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2017
2	Necrosis 01/2021 - 10/2016
2	Amyloid Plaque 01/2021 - 10/2003
2	Prehypertension 01/2019 - 01/2018
2	Insulin Resistance 01/2019 - 06/2014
2	Fatty Liver 03/2018 - 07/2017
2	Hyperglycemia 07/2017 - 02/2010
2	Metabolic Diseases (Metabolic Disease) 08/2016 - 02/2010
2	Hearing Loss (Hearing Impairment) 04/2016 - 12/2015
2	Rheumatoid Arthritis 01/2016 - 08/2004
2	Atrial Fibrillation 07/2014 - 06/2011
2	Angina Pectoris 04/2012 - 02/2009
2	Auditory neuropathy 08/2011 - 10/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010 - 01/2010
2	Diabetes Mellitus 02/2010 - 02/2010
2	Obesity 01/2010 - 09/2009
2	Cognitive Dysfunction 05/2008 - 06/2007
2	Neuroblastoma 01/2008 - 10/2003
1	Pathologic Processes 04/2024
1	Weight Loss (Weight Reduction) 02/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	COVID-19 02/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2002
14	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2019 - 01/2003
11	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2008
10	HDL LipoproteinsIBA 02/2021 - 01/2008
10	LipidsIBA 01/2019 - 02/2010
9	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2014 - 01/2003
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2007
7	Plasminogen Activators (Plasminogen Activator)IBA 05/2014 - 02/2006
6	Complementary DNA (cDNA)IBA 01/2013 - 01/2008
5	AntioxidantsIBA 02/2021 - 02/2010
5	CholesterolIBA 01/2021 - 01/2008
5	HDL CholesterolIBA 01/2021 - 01/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 06/2009
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2011 - 04/2007
5	Phosphotransferases (Kinase)IBA 06/2009 - 02/2004
5	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2009 - 01/2003
5	SB 203580IBA 01/2009 - 01/2003
4	oxidized low density lipoproteinIBA 01/2021 - 02/2010
4	ApolipoproteinsIBA 01/2021 - 01/2008
4	policosanolIBA 01/2019 - 01/2018
4	Cholesterol Ester Transfer ProteinsIBA 03/2018 - 01/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 01/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2008 - 01/2003
3	Triglycerides (Triacylglycerol)IBA 07/2014 - 01/2008
3	p38 Mitogen-Activated Protein KinasesIBA 01/2009 - 01/2003
3	PlasminogenIBA 07/2008 - 01/2003
3	Monoclonal AntibodiesIBA 01/2008 - 02/2004
2	Leucine (L-Leucine)FDA Link 04/2024 - 09/2004
2	Insulin (Novolin)FDA Link 02/2024 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 02/2020
2	GalactosidasesIBA 01/2022 - 01/2021
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2006
2	Hormones (Hormone)IBA 01/2019 - 11/2017
2	CreatinineIBA 01/2018 - 01/2010
2	ClusterinIBA 01/2018 - 06/2014
2	Interleukin-8 (Interleukin 8)IBA 01/2013 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 10/2003
2	Mitogen-Activated Protein KinasesIBA 06/2009 - 02/2004
2	Insulin-Like PeptidesIBA 02/2009 - 09/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2008 - 03/2006
2	Urokinase Plasminogen Activator ReceptorsIBA 03/2006 - 02/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2006 - 01/2003
1	Fibronectins (Fibronectin)IBA 04/2024
1	Surface-Active Agents (Surfactants)IBA 06/2022
1	CollagenIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	nintedanibIBA 01/2022
1	CateninsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 02/2021
1	LigandsIBA 01/2021
1	Selenoprotein WIBA 01/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021

Therapy/Procedure

10	Therapeutics 01/2016 - 07/2006
3	Cochlear Implants (Cochlear Implant) 01/2017 - 08/2011
3	Cochlear Implantation 04/2016 - 10/2007
1	Oral Administration 03/2024
1	Electrodes (Electrode) 06/2022